| Literature DB >> 31696981 |
Chao Chen1, Xiang Ni1, Shaorui Jia1, Yong Liang2, Xiaoli Wu3, Deling Kong1,4, Dan Ding1,4.
Abstract
Immunogenic cell death (ICD) provides momentous theoretical principle for modern cancer immunotherapy. However, the currently available ICD inducers are still very limited and photosensitizer-based ones can hardly induce sufficient ICD to achieve satisfactory cancer immunotherapy by themselves. Herein, an organic photosensitizer (named TPE-DPA-TCyP) with a twisted molecular structure, strong aggregation-induced emission activity, and specific ability is reported for effectively inducing focused mitochondrial oxidative stress of cancer cells, which can serve as a much superior ICD inducer to the popularly used ones, including chlorin e6 (Ce6), pheophorbide A, and oxaliplatin. Furthermore, more effective in vivo ICD immunogenicity of TPE-DPA-TCyP than Ce6 is also demonstrated using a prophylactic tumor vaccination model. The underlying mechanism of the effectiveness and robustness of TPE-DPA-TCyP in inducing antitumor immunity and immune-memory effect in vivo is verified by immune cell analyses. This study thus reveals that inducing focused mitochondrial oxidative stress is a highly effective strategy to evoke abundant and large-scale ICD.Entities:
Keywords: aggregation-induced emission; cancer immunotherapy; immunogenic cell death inducer; mitochondrial targeting; photosensitizers
Mesh:
Substances:
Year: 2019 PMID: 31696981 DOI: 10.1002/adma.201904914
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849